RP

Ramesh Purohit

Active Director Director DIN 06795626
DIN 06795626 First appointment Feb 2014 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value •••• Premium profile

About Ramesh Purohit

Data last updated:

Ramesh Purohit is a Director at Advika Pharma Private Limited (since 2014). The company operates in Chemicals. Advika Pharma Private Limited reported revenue of ₹1,680 (FY 2019).

DIN 06795626
Primary Designation Director
Industry Chemicals
First Appointment 12 Feb 2014
Oldest Company Age 12 yrs
Largest company Advika Pharma Private Limited · ₹1,680 (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advika Pharma Private Limited U24100MP2014PTC032366
Director12 Feb 20142014₹1,680 (FY 2019)Active

Board colleagues of Ramesh Purohit

NameDINCompanyDesignation
Purohit Padma06795630Advika Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Advika Pharma Private Limited
Premium access

Shareholding and investment profile for Ramesh Purohit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramesh Purohit

Ramesh Purohit currently holds 1 directorship: Advika Pharma Private Limited (Director, since 12 Feb 2014, revenue ₹1,680 (FY 2019)).

Ramesh Purohit was first appointed on 12 Feb 2014 as Director at Advika Pharma Private Limited.

The current boards of Ramesh Purohit's companies include Purohit Padma (Advika Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available